ES2106998T3 - Esteres de l-carnitina y acil-l-carnitina dotados de actividad relajante de los musculos, selectiva en el tracto gastro-intestinal y composiciones farmaceuticas que los contienen. - Google Patents

Esteres de l-carnitina y acil-l-carnitina dotados de actividad relajante de los musculos, selectiva en el tracto gastro-intestinal y composiciones farmaceuticas que los contienen.

Info

Publication number
ES2106998T3
ES2106998T3 ES93830083T ES93830083T ES2106998T3 ES 2106998 T3 ES2106998 T3 ES 2106998T3 ES 93830083 T ES93830083 T ES 93830083T ES 93830083 T ES93830083 T ES 93830083T ES 2106998 T3 ES2106998 T3 ES 2106998T3
Authority
ES
Spain
Prior art keywords
carnitine
acil
esters
selective
gastro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93830083T
Other languages
English (en)
Inventor
Nazareno Scafetta
Mose Santaniello
Maria Ornella Tinti
Domenico Misiti
Maria Antonietta Stasi
Loredana Vesci
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Sigma Tau Industrie Farmaceutiche Riunite SpA
Application granted granted Critical
Publication of ES2106998T3 publication Critical patent/ES2106998T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

ESTERES DE L-CARNITINA Y L-CARNITINA DE ACILO DE FORMULA (I): DONDE R ES HIDROGENO O ES UN GRUPO ACILO SATURADO O NO SATURADO, RECTO O RAMIFICADO CON 2 A 26 ATOMOS DE CARBONO; R1 ES UN GRUPO ACILO SATURADO O NO SATURADO, RECTO O RAMIFICADO CON 4 A 26 ATOMOS DE CARBONO; Y X EUTICAMENTE ACEPTABLE, ESTAN DOTADOS DE ACTIVIDAD SELECTIVA RELAJANTE DE MUSCULO EN EL TRACTO GASTROINTESTINAL Y SON POR TANTO UTILES TERAPEUTICAMENTE PARA EL TRATAMIENTO DE, POR EJEMPLO, SINDROMES DE COLITIS ADAPTABLE.
ES93830083T 1992-03-02 1993-03-01 Esteres de l-carnitina y acil-l-carnitina dotados de actividad relajante de los musculos, selectiva en el tracto gastro-intestinal y composiciones farmaceuticas que los contienen. Expired - Lifetime ES2106998T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITRM920138A IT1258370B (it) 1992-03-02 1992-03-02 Esteri della l-carnitina e di acil l-carnitine dotati di attivita' miorilassante selettiva sull'apparato gastro-intestinale e composizioni farmaceutiche che li contengono.

Publications (1)

Publication Number Publication Date
ES2106998T3 true ES2106998T3 (es) 1997-11-16

Family

ID=11400749

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93830083T Expired - Lifetime ES2106998T3 (es) 1992-03-02 1993-03-01 Esteres de l-carnitina y acil-l-carnitina dotados de actividad relajante de los musculos, selectiva en el tracto gastro-intestinal y composiciones farmaceuticas que los contienen.

Country Status (8)

Country Link
EP (1) EP0559625B1 (es)
AT (1) ATE157348T1 (es)
DE (1) DE69313325T2 (es)
DK (1) DK0559625T3 (es)
ES (1) ES2106998T3 (es)
GR (1) GR3025093T3 (es)
HK (1) HK1006368A1 (es)
IT (1) IT1258370B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5607691A (en) * 1992-06-12 1997-03-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
IT1261231B (it) * 1993-04-08 1996-05-09 Sigma Tau Ind Farmaceuti Procedimento migliorato per la preparazione di l-(-)-carnitina a partire da un prodotto di scarto avente opposta configurazione.
IT1261828B (it) 1993-07-14 1996-06-03 Sigma Tau Ind Farmaceuti Esteri di acil l-carnitine e composizioni farmaceutiche che li contengono per il trattamento dello shock endotossico.
US5741816A (en) * 1994-06-20 1998-04-21 Tanabe Seiyaku Co., Ltd. Hair-growth agent
AU718308B2 (en) * 1996-05-31 2000-04-13 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Stable, non-hygroscopic salts of L(-)carnitine and alkanoyl L(-)carnitines, a process for their preparation and solid, orally administrable compositions containing such salts
IT1284661B1 (it) * 1996-06-06 1998-05-21 Sigma Tau Ind Farmaceuti Uso di alcanoil l-carnitine nel trattamento terapeutico di malattie infiammatorie croniche intestinali.
IT1299172B1 (it) * 1998-05-06 2000-02-29 Sigma Tau Ind Farmaceuti Esteri perfluorurati di alcanoil l-carnitine utilizzabili quali lipidi cationici per l'immissione intracellulare di composti
IT1306129B1 (it) * 1999-04-13 2001-05-30 Sigma Tau Ind Farmaceuti Esteri della l-carnitina o di alcanoil l-carnitine utilizzabili comelipidi cationici per l'immissione intracellulare di composti
AU2007214359B2 (en) * 1999-04-13 2009-02-12 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds
US11103588B2 (en) * 2017-06-06 2021-08-31 Wayne State University Methods and compositions relating to carnitine-derived materials
CN111601512B (zh) * 2019-03-06 2023-11-17 彭险峰 γ-季铵基丁酸酯类化合物在制备动物饲料添加剂中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1116037B (it) * 1979-04-23 1986-02-10 Sigma Tau Ind Farmaceuti Esteri e ammidi di acil carnitine loro procedimenti di preparazione e loro uso terapeutico
IT1147079B (it) * 1980-05-30 1986-11-19 Sigma Tau Ind Farmacuetiche Ri Esteri di alcossi-acil derivati della carnitina procedimento per la loro preparatione e composizioni farmaceutiche che li contengono
IT1209564B (it) * 1984-06-29 1989-08-30 Magis Farmaceutici Derivati della l-carnitina o di l-acil carnitina.
IT1254136B (it) * 1992-01-16 1995-09-08 Sigma Tau Ind Farmaceuti Esteri di acil carnitine con alcooli alifatici a lunga catena e composizioni farmaceutiche che li contengono, ad attivita' antimicotica.

Also Published As

Publication number Publication date
DE69313325T2 (de) 1998-01-29
IT1258370B (it) 1996-02-26
ITRM920138A0 (it) 1992-03-02
DE69313325D1 (de) 1997-10-02
EP0559625A2 (en) 1993-09-08
HK1006368A1 (en) 1999-02-26
EP0559625A3 (en) 1993-12-01
EP0559625B1 (en) 1997-08-27
GR3025093T3 (en) 1998-01-30
ITRM920138A1 (it) 1993-09-02
ATE157348T1 (de) 1997-09-15
DK0559625T3 (da) 1997-12-29

Similar Documents

Publication Publication Date Title
ES2106998T3 (es) Esteres de l-carnitina y acil-l-carnitina dotados de actividad relajante de los musculos, selectiva en el tracto gastro-intestinal y composiciones farmaceuticas que los contienen.
IT1256450B (it) Esteri nitrici con attivita' farmacologica e procedimento per la loro preparazione
KR890001533A (ko) 레보도파 메틸 에스테르를 함유하는 제약 조성물, 이들의 제조 및 치료학적 응용
FI875229A (fi) Menetelmä uusien farmakologisesti aktiivisten katekolijohdoksien valmistamiseksi
MX9205466A (es) Procedimiento para la preparacion de un medicamento para la administracion oral o topica en el tratamiento de leishmaniasis
DE69006116T2 (de) Peptid-Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
BG102647A (en) Acyclic nucleoside derivatives
ZA9110037B (en) The use of acetyl l-carnitine in the therapeutic treatment of coma and pharmacological compositions useful in such treatment
IE830411L (en) 4``-epi-erythromycin a
CA2227533A1 (en) Improved therapeutic agents
JPS5353636A (en) Preparatin of highly pure aromatic dicarboxylic acid dichloride
ATE43348T1 (de) Acylierte cytidin-diphosphat-choline, verfahren zu ihrer herstellung und ihre therapeutische verwendung.
GB8620917D0 (en) Platinum derivatives & cancer treatments
ES2111297T3 (es) Nuevos esteres de acidos carboxilicos de 2-amino-7-(1,3-dihidroxi-2-propoximetil)purina, su preparacion asi como su empleo.
GR3015142T3 (en) Pharmaceutical compositions and lactosyl compounds, and their preparation.
EP0014981A3 (en) Medicaments and pharmaceutical compositions with cytostatic activity
KR890009868A (ko) 1-메틸-β-옥소-α-(페닐카바모일)-2- 피롤프로피오니트릴의 트로메트아민염
ES2096115T3 (es) Uso de derivados de xantina para el tratamiento de lesiones musculares despues de la interrupcion completa de la circulacion sanguinea.
KR910000155A (ko) 인간 및 수의학에서의 서맥 및 부정서맥을 치료하기위한 11위치-치환된 5,11-디하이드로-6H-피리도 [2.3-b] [1.4]-벤조디아제핀-6-온의 용도
GB2023001A (en) Anti-neoplastic compositions containing esterified glycyrrhetinic acid
JPS5432493A (en) Preparation of macrolide antibiotics derivatives
JPS52122302A (en) Elimination of peptide protecting group
ES2046141B1 (es) "procedimiento para la obtencion del acido 2-((2,6-diclorofenil)amino) fenilacetoxiacetico"
JPS5214058A (en) Floor heating device by coupled light-weight panel
IT1245390B (it) Composizione farmaceutica ad attivita' antivirale

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 559625

Country of ref document: ES